← back to search

Amagana Dolo

Universidad Tecnológica de Panamá ·
Area of research
Public Health, Environmental and Occupational Health · Molecular Biology
Research interest
Research interests include Malaria Research and Control, vaccines and immunoinformatics approaches, Mosquito-borne diseases and control, and Parasites and Host Interactions.
h-index
44
citations
6,098
works
163
NIH funding
primary concept
Medicine
email

Recent publications

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
The Lancet 2024cited by 338position: middledoi
Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial
The Lancet Infectious Diseases 2023cited by 64position: middledoi
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
New England Journal of Medicine 2021cited by 234position: middledoi
The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine
Clinical Infectious Diseases 2021cited by 10position: middledoi
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
The Lancet Haematology 2018cited by 121position: middledoi
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults
The Lancet Infectious Diseases 2018cited by 102position: middledoi
Genetic determinants of anti-malarial acquired immunity in a large multi-centre study
Malaria Journal 2015cited by 28position: middledoi
Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali
Malaria Journal 2014cited by 46position: middledoi
Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
PLoS ONE 2013cited by 42position: middledoi
Human Candidate Polymorphisms in Sympatric Ethnic Groups Differing in Malaria Susceptibility in Mali
PLoS ONE 2013cited by 41position: middledoi
Fc gamma Receptor <scp>II</scp>a‐<scp>H</scp>131<scp>R</scp> Polymorphism and Malaria Susceptibility in Sympatric Ethnic Groups, Fulani and Dogon of <scp>M</scp>ali
Scandinavian Journal of Immunology 2013cited by 29position: middledoi
Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso
BMC Research Notes 2012cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Susana Campino · London School of Hygiene & Tropical Medicine3 papers (2013–2014)Taane G. Clark · London School of Hygiene & Tropical Medicine3 papers (2013–2014)Patrick H. Corran · London School of Hygiene & Tropical Medicine3 papers (2013–2014)Kirk A. Rockett · Centre for Human Genetics3 papers (2013–2014) · 3 papers (2012–2014)Nuno Sepúlveda · Warsaw University of Technology3 papers (2013–2014)Ogobara K. Doumbo · Institut National de Recherche en Santé Publique3 papers (2013–2014)Ousmane Touré · National Institute of Allergy and Infectious Diseases2 papers (2013–2013) · 2 papers (2013–2013)Amadou Tapily · Université des Sciences, des Techniques et des Technologies de Bamako2 papers (2013–2013) · 2 papers (2013–2014)Federica Verra · London School of Hygiene & Tropical Medicine1 papers (2012–2012)Alphonse Ouédraogo · Sanaria1 papers (2012–2012)Amidou Diarra · Centre for Human Genetics1 papers (2012–2012)Charlotte Behr · Institut Pasteur1 papers (2012–2012) · 1 papers (2013–2013)David Modiano · Centre for Human Genetics1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2013–2013)